Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Glioblastoma 5Carcinoma, Non-Small-Cell Lung 5Squamous Cell Carcinoma of Head and Neck 4Rectal Neoplasms 4Neoplasms 4Head and Neck Neoplasms 4Colorectal Neoplasms 4Stomach Neoplasms 3Glioma 3Esophageal Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Brain Neoplasms 3Astrocytoma 3Sarcoma 2Pancreatic Neoplasms 2Osteosarcoma 2Lung Neoplasms 2Carcinoma, Squamous Cell 2Wilms Tumor 1Urinary Bladder Neoplasms 1Skin Neoplasms 1Sinonasal Squamous Cell Carcinoma 1Rhabdomyosarcoma 1Recurrence 1Radiation Injuries 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Postoperative Complications 1Pilonidal Sinus 1

Interventions

pembrolizumab 52Paclitaxel 19Cisplatin 14Carboplatin 14lenvatinib 10Docetaxel 8Saline Solution 7Capecitabine 7Pemetrexed 6Oxaliplatin 6Gemcitabine 6Fluorouracil 6Leucovorin 5Albumin-Bound Paclitaxel 5olaparib 4belzutifan 4Bevacizumab 4130-nm albumin-bound paclitaxel 4patritumab deruxtecan 3Glucose 3Acetaminophen 3liposomal doxorubicin 2Levoleucovorin 2Irinotecan 2Histamine H2 Antagonists 2Histamine Antagonists 2Etoposide 2Doxorubicin 2Dexamethasone 2Cetuximab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body × Surgical Procedures, Operative × 90 days × Clear all
NCT03924856 2026-05-28

KEYNOTE-866

Merck Sharp & Dohme LLC

Phase 3 Completed
907 enrolled
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡